Join the club for FREE to access the whole archive and other member benefits.

Sebastian Aguiar Brunemeier

Geroscientist + VC. Investing in the science of aging and rejuvenation and Oxford biochemist

Sebastian Aguiar is a geroscientist and co-founder at Cambrian Biopharma. Sebastian is Founder and COO of Samsara Therapeutics, an Apollo Ventures-incubated company focused on geroprotector drug discovery.

Prior to Apollo, Sebastian was an Associate at Deep Knowledge Ventures in London, a Fulbright Research Fellow at the Telomere and Genomic Stability Laboratory of the Gulbenkian Institute, employee #4 at Pascal Chemistry, a VC finance researcher at the California Institute of Technology (Caltech), and a SENS Research Scholar at the Buck Institute for Research on Aging.

Sebastian was a Clarendon Scholar at the University of Oxford for his DPhil (PhD) on the biochemistry of aging, holds an MSc in Biomedical Science from the University of Amsterdam where he was an Amsterdam Excellence Scholar, an MSc in Life Science Business Management from the VU Amsterdam, and a B.A. with honors in Human Biology from Pitzer College, Claremont University Consortium.

Visit website:




See also: Company Samsara Therapeutics - Company developing therapeutics for life extension.

Details last updated 10-Sep-2020

Sebastian Aguiar Brunemeier is also referenced in the following:

ARDD 2023 - 10th Aging Research & Drug Discovery Meeting

28-Aug-2023 to 01-Sep-2023

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

Longevity Biotech: Investing in 21st Century Medicines


Online event about biotechnology and longevity industry with talk from biotech VC Sebastian A. Brunemeier

Longevity Hackers

Feature length documentary about longevity and radical life extension with due to be released in 2023

Longevity State Conference 2024


Conference about longevity, its social changes and aging organised by Vitalism Foundation (Cofrentes, Spain)